Skip to main content
. 2020 Mar 4;33(5):483–496. doi: 10.1111/tri.13592

Table 3.

Baseline characteristics of patients included in meta‐analysis.

Characteristics Studies nVC Total patients Any VC Total patients P‐value
Recipient age, mean (SD) 61,22,23,25,26,27 42.0 (12.4) 2529 54.3 (10.8) 721 <0.001*
Male sex, n (%) 51,22,23,26,27 977 (63.9) 1528 421 (64.6) 652 0.779
Smoking, n (%) 222,23 99 (19.5) 508 59 (19.5) 302 <0.986
Hypertension, n (%) 41,22,23,27 1106 (75.8) 1459 518 (86.0) 602 <0.001*
DM, n (%) 51,22,23,26,27 160 (10.5) 1528 211 (32.4) 652 <0.001*
Hypercholesterolemia, n (%) 31,23,27 387 (27.9) 1385 251 (44.3) 567 <0.001*
Pre‐emptive KTx, n (%) 51,22,23,25,26 176 (7.3) 2422 113 (16.3) 694 <0.001*
Living donor, n (%) 31,22,25 41 (2.1) 1919 20 (5.3) 377 <0.001*
History MI, n (%) 222,23 34 (6.7) 508 43 (14.2) 302 <0.001*
History CVA/TIA, n (%) 222,23 28 (5.5) 508 27 (8.9) 302 0.061

CVA, cerebrovascular accident; DM, diabetes mellitus; KTx, kidney transplantation; MI, myocardial infarction; nVC, no vascular calcification; SD, standard deviation; TIA, transient ischemic attack; VC, vascular calcification.

1